Esophageal lipoma is a rare benign mesenchymal tumor originating from submucosal fat tissue, constituting less than 1% of all esophageal tumors. The esophagus is the rarest location among all gastrointestinal lipomas; colon and small bowel are much more frequently involved. Typically occurs between ages 40-60 with no significant gender predilection. Most lipomas are asymptomatic and incidental findings; however, large lesions (>4 cm) may cause dysphagia, odynophagia, or obstructive symptoms. Fat density (-50 to -120 HU) on CT is pathognomonic and no further workup is needed. High signal on T1-weighted MRI images with marked signal loss on fat suppression confirms the diagnosis. There is no risk of malignant transformation. Endoscopic or surgical excision is curative for symptomatic lesions.
Age Range
40-80
Peak Age
60
Gender
Equal
Prevalence
Rare
Lipoma is composed of benign proliferation of mature adipocytes surrounded by a thin fibrous capsule. Esophageal lipoma is extremely rare because fat tissue is minimal in the esophageal submucosa. The tumor consists entirely of mature fat cells — contains no atypical mitotic figures or lipoblasts (distinguishing feature from liposarcoma). Homogeneous fat content forms the basis of imaging findings: the low X-ray attenuation of fat tissue (low electron density and low atomic number of fat molecules) produces negative density values between -50 and -120 HU on CT. On MRI, the short T1 relaxation time of fat protons appears as high signal on T1-weighted images. On fat suppression sequences (STIR or frequency-selective fat suppression), the applied inversion pulse or frequency-selective RF pulse selectively suppresses fat proton signal — causing marked signal loss in lipoma and confirming the diagnosis. Lipomas grow very slowly, and chromosomal anomalies (12q13-15 translocations) likely play a role in pathogenesis. Malignant transformation has not been reported.
Homogeneous fat density (-50 to -120 HU) on CT is the pathognomonic finding that distinguishes esophageal lipoma from all other submucosal tumors. It is diagnostic on its own and requires no additional workup.
Well-defined submucosal mass with homogeneous fat density (-50 to -120 HU) in the esophageal wall on non-contrast CT. Density values are identical to subcutaneous fat tissue. Thin capsule may be visible as a high-density rim. No calcification, soft tissue component, or septation within the internal structure. This homogeneous fat density is pathognomonic for lipoma and diagnostic on its own.
Report Sentence
Well-defined submucosal mass with homogeneous fat density (-XX HU) is observed in the esophageal wall; this appearance is pathognomonic for lipoma.
Lipoma shows no enhancement on contrast-enhanced CT. Density values of the lesion in arterial and portal venous phases are identical to those on non-contrast scan. This avascularity results from the tumor consisting entirely of mature adipocytes without capillary vascular network. Absence of enhancement supports benign fat tumor diagnosis and is important in differentiating lipoma from liposarcoma (which contains heterogeneously enhancing soft tissue component).
Report Sentence
The lesion demonstrates no enhancement on contrast-enhanced series; this avascular characteristic is consistent with benign lipoma diagnosis.
Lipoma shows high signal isointense to subcutaneous fat on T1-weighted images. Signal is homogeneous and uniform. Thin capsule may be visible as a thin low-signal line. No heterogeneity, nodularity, or enhancing component within the internal structure. This homogeneous T1 hyperintense signal strongly suggests fat content but signal loss on fat suppression sequence is needed for definitive diagnosis.
Report Sentence
The lesion demonstrates homogeneous high signal isointense to subcutaneous fat on T1-weighted images; consistent with fat-containing lesion.
Marked and homogeneous signal loss in lipoma on fat suppression sequences (STIR or frequency-selective fat suppression). Signal loss is uniform throughout the entire lesion — no focal preserved areas. This finding definitively proves the lesion is entirely fat-containing and is critical in differentiating from other T1 hyperintense lesions (melanoma metastasis, hemorrhagic lesion). In liposarcoma, there are soft tissue components that retain signal alongside areas showing signal loss on fat suppression.
Report Sentence
The lesion demonstrates homogeneous and complete signal loss on fat suppression sequence; this finding proves the lesion is entirely fat-containing, confirming the diagnosis of lipoma.
On EUS, submucosal, hyperechoic, homogeneous, oval mass. The high acoustic impedance of fat content causes brighter imaging compared to surroundings. The lesion is compressible (soft fat tissue) and shows no posterior acoustic shadowing. Muscularis layer is intact and separate from the lesion. Smooth borders and homogeneous internal structure support benignity.
Report Sentence
On EUS, a well-defined, homogeneous hyperechoic mass originating from the submucosal layer of the esophageal wall is observed; consistent with fat-containing submucosal lesion (lipoma).
Lipoma shows intermediate-to-high signal on T2-weighted images, isointense to subcutaneous fat. Signal is homogeneous. Fat signal on T2 may vary depending on sequence type and parameters (fat is bright on fast spin-echo sequences, less bright on conventional spin-echo). Signal is completely suppressed on STIR sequence.
Report Sentence
The lesion demonstrates homogeneous intermediate-to-high signal isointense to subcutaneous fat on T2-weighted images.
Criteria
Composed entirely of mature adipocytes. Homogeneous fat density, no enhancement. Most common type.
Distinct Features
Uniform -50 to -120 HU on CT, complete signal loss on MRI fat suppression. No soft tissue component.
Criteria
Composed of mixture of fat tissue and fibrous tissue. Thin septa of soft tissue density may be seen in addition to fat density on CT. Still benign.
Distinct Features
Thin soft tissue septa within fat density on CT. Most loses signal on MRI fat suppression, septa are preserved. Enhancement minimal.
Criteria
Rare variant containing fat tissue and vascular elements. Capillary vessels present between mature adipocytes. May be associated with pain (unlike other lipomas).
Distinct Features
Mildly enhancing vascular component may be seen within fat density on CT. Vascular flow voids may be seen on MRI. Most signal lost on fat suppression.
Distinguishing Feature
Fibrovascular polyp contains both fat and soft tissue density (mixed density) — different from lipoma's homogeneous fat density. Fibrovascular polyp is usually long, pedunculated and originates from upper esophagus.
Distinguishing Feature
Leiomyoma is a soft tissue density (30-50 HU) mass without fat density. Originates from muscularis layer (4th layer), while lipoma is submucosal (3rd layer).
Distinguishing Feature
Liposarcoma contains fat but also non-adipose soft tissue components (thick septa, nodules), heterogeneity and enhancing areas — different from lipoma's homogeneous fat content. ADC values are low.
Distinguishing Feature
Schwannoma is a soft tissue signal mass without fat content. Shows marked T2 hyperintense signal (Antoni B areas). No signal loss on fat suppression.
Urgency
routineManagement
conservativeBiopsy
Not NeededFollow-up
no-follow-upEsophageal lipoma is a benign tumor with no risk of malignant transformation. Diagnosis is confirmed when typical fat density/signal is identified on CT or MRI and biopsy is not needed. Asymptomatic small lipomas require no follow-up or treatment. Endoscopic mucosal resection (small lesions) or surgical enucleation (large lesions) is curative for symptomatic lesions. Recurrence is extremely rare.
Esophageal lipomas require no treatment. Endoscopic or surgical resection can be performed for symptomatic lesions. There is no risk of malignant transformation. Definitive diagnosis is made by fat density, no biopsy needed.